TargetMol

Cianergoline

Product Code:
 
TAR-T25247
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T25247-5mg5mg£930.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25247-50mg50mg£1,821.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25247-100mg100mg£2,319.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Cianergoline is a dopaminergic agonist.
CAS:
74627-35-3
Formula:
C19H22N4O
Molecular Weight:
322.412
Purity:
0.98
SMILES:
[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@@H](CC(C#N)C(N)=O)CN2C

References

1. Potter DE, Shumate DJ. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function. J Ocul Pharmacol. 1987 Winter;3(4):309-21. PubMed PMID: 3503920. 2. Bise G, Foletti C, Beretta-Piccoli C, Weidmann P, Ziegler WH, Mordasini R, Bachmann C. Effects of the dopaminergic agonist cianergoline on blood pressure, the renin-angiotensin-aldosterone axis and the sympathetic nervous system in patients with essential hypertension. Eur J Clin Pharmacol. 1985;29(1):25-31. PubMed PMID: 4054204. 3. Ohno S, Koumori M, Adachi Y, Mizukoshi K, Nagasaka M, Ichihara K. Synthesis and structure-activity relationships of new (5R,8S,10R)-ergoline derivatives with antihypertensive or dopaminergic activity. Chem Pharm Bull (Tokyo). 1994 Oct;42(10):2042-8. PubMed PMID: 7805128. 4. Salvati P, Caravaggi AM, Lamberti E, Monteggia M, Bianchi G. Cardiovascular effects of a new antihypertensive agent in several species. Arzneimittelforschung. 1983;33(8):1098-106. PubMed PMID: 6685486.